The market expects Huntington Bancshares (HBAN) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known ...

The Company will host a conference call to review quarterly financial results at 9 a.m. ET.

In a report released on January 8, Jon Arfstrom from RBC Capital maintained a Buy rating on Huntington Bancshares (HBAN – Research Report), ...

HBAN introduces two new industry verticals. This expansion supports the bank's broader efforts to diversify and enhance its ...

In a report released on January 7, Andrew J Dietrich from J.P. Morgan maintained a Buy rating on Huntington Bancshares (HBAN – Research ...

The stock's fall snapped a three-day winning streak.

Huntington Bancshares Inc (HBAN) stock saw a modest uptick, ending the day at $16.55 which represents a slight increase of $0.02 or 0.12% from the prior close of $16.53. The stock opened at $16.66 and ...

Deciphex, which is based in the DCU Alpha campus, has acquired the funds following a substantial funding round led by Molten ...

The funding will be used to expand the firm's global services, enhance its core platforms, and accelerate the development of pathology foundational models.

Company to create 90 new jobs across the group as CEO Donal O’Shea talks of a major milestone for the firm as Molten Ventures ...

Digital pathology company Deciphex has raised $32.3 million (€31 million) from investors in a new funding round that will ...

Neville Rodie & Shaw Inc. acquired a new stake in Huntington Bancshares Incorporated (NASDAQ:HBAN – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the ...